- Home
- RGNX vs EBF Comparison
RGNX vs EBF Comparison
Compare RGNX & EBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGNX | EBF |
|---|---|---|
| Founded | 2008 | 1909 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Office Equipment/Supplies/Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 528.6M | 533.9M |
| IPO Year | 2015 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RGNX | EBF |
|---|---|---|
| Price | $6.21 | $20.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $28.75 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 164.9K |
| Earning Date | 05-05-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 4.85% |
| EPS Growth | ★ 18.08 | 7.79 |
| EPS | N/A | ★ 1.66 |
| Revenue | ★ $10,393,000.00 | N/A |
| Revenue This Year | $51.21 | $2.96 |
| Revenue Next Year | $19.08 | N/A |
| P/E Ratio | ★ N/A | $12.18 |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $6.02 | $16.30 |
| 52 Week High | $16.19 | $22.36 |
Technical Indicators
Market Signals| Indicator | RGNX | EBF |
|---|---|---|
| Relative Strength Index (RSI) | 28.35 | 42.97 |
| Support Level | N/A | $19.96 |
| Resistance Level | $9.67 | $21.39 |
| Average True Range (ATR) | 0.76 | 0.43 |
| MACD | -0.16 | -0.03 |
| Stochastic Oscillator | 4.30 | 22.55 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
About EBF Ennis Inc.
Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialties, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360 Custom LabelsSM, ColorWorx, Enfusion, among others.